We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNT
401
DELISTED
Verint Systems
VRNT
| $2.19M | 0.04% |
114,129
+48,094
| +73% | +$866K |
|
402
Teledyne Technologies
TDY
$30.4B
| $2.19M | 0.04% |
20,265
-70,528
| -78% | -$7.44M |
|
403
Kohl's
KSS
$2.03B
| $2.17M | 0.04% |
49,570
-1,640
| -3% | -$68.7K |
|
404
Emergent Biosolutions
EBS
$375M
| $2.14M | 0.04% |
68,013
-27,902
| -29% | -$811K |
|
405
National Bank Holdings
NBHC
$1.93B
| $2.13M | 0.04% |
91,032
-24,344
| -21% | -$538K |
|
406
ICU Medical
ICUI
$3.93B
| $2.12M | 0.04% |
16,800
+5,600
| +50% | +$675K |
|
407
American Water Works
AWK
$26.3B
| $2.1M | 0.04% |
28,090
-4,320
| -13% | -$338K |
|
408
Regions Financial
RF
$26.3B
| $2.09M | 0.04% |
212,000
+53,320
| +34% | +$499K |
|
|
PMC
409
DELISTED
PharMerica Corporation
PMC
| $2.09M | 0.04% |
74,450
-36,430
| -33% | -$934K |
|
410
Hain Celestial
HAIN
$47.8M
| $2.07M | 0.04% |
58,191
+19,900
| +52% | +$872K |
|
411
MarineMax
HZO
$800M
| $2.06M | 0.04% |
+98,300
| New | +$1.93M |
|
|
WGL
412
DELISTED
Wgl Holdings
WGL
| $2.02M | 0.04% |
32,290
| – | – |
|
413
LivaNova
LIVN
$4.3B
| $2.02M | 0.04% |
33,640
| – | – |
|
|
PSB
414
DELISTED
PS Business Parks, Inc.
PSB
| $2.02M | 0.04% |
17,800
+1,860
| +12% | +$205K |
|
415
MYR Group
MYRG
$5.9B
| $2M | 0.04% |
66,475
+1,110
| +2% | +$30.4K |
|
|
VTLE
416
DELISTED
Vital Energy
VTLE
| $2M | 0.04% |
7,752
-3,146
| -29% | -$718K |
|
417
American Homes 4 Rent
AMH
$12B
| $1.98M | 0.04% |
+91,600
| New | +$1.98M |
|
|
HOLX
418
DELISTED
Hologic
HOLX
| $1.96M | 0.03% |
50,368
-5,430
| -10% | -$205K |
|
419
Henry Schein
HSIC
$9.74B
| $1.95M | 0.03% |
+30,575
| New | +$2.03M |
|
420
RE/MAX Holdings
RMAX
$200M
| $1.94M | 0.03% |
44,330
-23,238
| -34% | -$983K |
|
421
Insteel Industries
IIIN
$633M
| $1.94M | 0.03% |
53,420
+25,580
| +92% | +$862K |
|
|
BRCD
422
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $1.94M | 0.03% |
209,680
-985,343
| -82% | -$9.18M |
|
|
AKS
423
DELISTED
AK Steel Holding Corp
AKS
| $1.92M | 0.03% |
398,074
-800
| -0.2% | -$4.06K |
|
|
DCH
424
Dauch Corp
DCH
$1.3B
| $1.92M | 0.03% |
111,393
-11,735
| -10% | -$197K |
|
|
ESL
425
DELISTED
Esterline Technologies
ESL
| $1.92M | 0.03% |
25,220
-260
| -1% | -$18.2K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.